In this exclusive interview, Chris Martin, Life Sciences Technical Accounting Consulting Leader at RSM US LLP, discusses the life sciences market, focusing on why biotech is the dominant sector within the life sciences for IPOs and capital raised. He also explores the SPAC boom and what life as a public company looks like after an IPO. Martin was speaking to Sharon Langan, Global Practice Leader for Informa Connect Life Sciences Global Finance & Accounting. Watch the full interview below (or here).
Is going public in your future? Download the RSM guide to going public.